Canaccord Genuity maintains a 'Hold' on MAKO Surgical (MAKO); Raising Q4 Revenuess, Lowering 2012 to Reflect Pre-announcement

Canaccord Genuity maintains a 'Hold' on MAKO Surgical (NASDAQ: MAKO) price target raised from $30 to $33.

Analyst, William J. Plovanic, said, "We maintain our rating on MAKO following the release of preliminary Q4/11 results with in-line system sales and strong US knee procedure volumes. We are updating our model going into the Q4/11 conference call to reflect preliminary results as well as adjusting our assumptions for continued commercialization of the hip application, resulting in higher revenues for Q4/11 but lower numbers for 2012."

For an analyst ratings summary and ratings history on MAKO Surgical click here. For more ratings news on MAKO Surgical click here.

Shares of MAKO Surgical closed at $37.13 yesterday, with a 52 week range of $15.40-$43.00.

---

Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!

You May Also Be Interested In

• Barclays Maintains an 'Overweight' on Tidewater (TDW); Dayrates Climb, But Adjusting Numbers Lower on Expenses
• QUAN Works to Take Robotics Out of the Lab and Into the Marketplace
• Goldman Sachs Defends J.P. Morgan (JPM); 'Down But Not Out'

Create E-mail Alert Related Categories

Analyst Comments

Related Entities

Genuity Capital Markets

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter